⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29239524 | 0.83 | — | — | |
| SCHEMBL23111352 | 0.79 | ACE2 (0.35) | — | |
| Potassium Ion SCHEMBL5157526 | 0.77 | — | — | |
| SCHEMBL1457083 | 0.77 | — | — | |
| SCHEMBL2223263 | 0.77 | — | — | |
| SCHEMBL1318886 | 0.77 | — | — | |
| SCHEMBL1648363 | 0.77 | — | — | |
| SCHEMBL5789431 | 0.77 | — | — | |
| SCHEMBL1080726 | 0.77 | — | — | |
| SCHEMBL28953684 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1364645-A1 | Pharmaceutical combinations for topical use based on iron chelators, metalloprotease inhibitors and factor XIII for the treatment of lipodermatosclerosis and trophic lesions of the cutaneous tissues and muccous membranes | ZAMBONI, Paolo (IT) | 2003-11-26 | — | — | EP | claimed |
| CN-119770677-A | Nanoscale curcumin-based metal organic framework material and preparation method thereof | 武汉理工大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-109582092-B | Auxiliary use device of mobile terminal and multimedia interaction system | 深圳市科迈爱康科技有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-116870029-A | Metal polyphenol-based nanoparticle, preparation method thereof and application thereof in treating acute kidney injury | 四川大学 | 2023-10-13 | — | — | CN | disclosed |
| CN-113769157-B | Injectable hydrogel and preparation method thereof | 西北大学 | 2022-08-05 | — | — | CN | disclosed |
| CN-113769157-A | Injectable hydrogel and preparation method thereof | 西北大学 | 2021-12-10 | — | — | CN | disclosed |
| CN-112788957-A | Aerosol-generating article and aerosol-generating system | 韩国烟草人参公社 | 2021-05-11 | — | — | CN | disclosed |
| CN-110612119-A | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | 西雅图儿童医院（DBA西雅图儿童研究所） | 2019-12-24 | — | — | CN | disclosed |
| CN-102749806-B | Colored curable resin composition | 住友化学株式会社 | 2016-10-26 | — | — | CN | disclosed |
| EP-2741731-A1 | ENCAPSULATES | The Procter and Gamble Company (US) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013022949-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |
| CN-102749806-A | Colored curable resin composition | SUMITOMO CHEMICAL CO | 2012-10-24 | — | — | CN | disclosed |
| WO-2012085864-A1 | ENCAPSULATES | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2012-06-28 | — | — | WO | disclosed |
| EP-1601367-A2 | THE COMBINED USE OF CRUCIFEROUS INDOLES AND CHELATORS FOR THE TREATMENT OF PAPILLOMAVIRUS-RELATED CONDITIONS | Bioresponse L.L.C. (US) | 2005-12-07 | — | — | EP | disclosed |
| US-20040225004-A1 | Combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions | BIORESPONSE, LLC | 2004-11-11 | — | — | US | disclosed |
| WO-2004071425-A2 | THE COMBINED USE OF CRUCIFEROUS INDOLES AND CHELATORS FOR THE TREATMENT OF PAPILLOMAVIRUS-RELATED CONDITIONS | BIORESPONSE, LLC (US) | 2004-08-26 | — | — | WO | disclosed |
| EP-1364645-A1 | Pharmaceutical combinations for topical use based on iron chelators, metalloprotease inhibitors and factor XIII for the treatment of lipodermatosclerosis and trophic lesions of the cutaneous tissues and muccous membranes | ZAMBONI, Paolo (IT) | 2003-11-26 | — | — | EP | disclosed |